H2O Innovation Inc. (“H2O Innovation” or the “Corporation”) is proud to announce that Clearlogx, its proprietary coagulant control technology, has recently won three (3) new projects in the United States, totalling $498,000. The Corporation now has its digital solutions installed on more than 50 sites.
This patented control technology, acquired by H2O Innovation, is used in both conventional and membrane filtration (MF/UF) systems to automatically adjust the feed of specialty coagulants based on a specific control algorithm. By optimizing the coagulant dosage in conventional or membrane treatment systems, this software can improve the performance of the plant, reducing costly carryover and/or membrane fouling, providing tremendous savings in chemical, energy, and maintenance costs.
Over the last few months, H2O Innovation has completed installation of three (3) new Clearlogx projects: one (1) in California and two (2) in North Carolina. The California contract was a result of additional scope to an existing H2O Innovation capital equipment project. This project also included the use of Zeta potential for optimal control of particle charge. Clearlogx can also be installed on system built by other system suppliers, as was the case for the two North Carolina contracts. For all three projects, Clearlogx was required to meet environmental regulations, reduce organics & disinfection by-products and minimize fouling of the membranes. All three of the systems associated with these recent Clearlogx projects were conventional clarification followed by membrane filtration.
“We are hitting our stride with this technology, finding the opportunities where it is a good fit in our market. With each of these projects we have been able to closely control chemical feed to optimize the process, leading to more efficient operation and less hassle for the operations staff. Clearlogx projects also put us in a good position to continue to support our customers through the supply of our specialty coagulants and the use of our Intelogx data monitoring software”, stated Gregory Madden, Vice President Aftermarket & Digital Solutions.
Clearlogx is a proprietary technology, which precisely and continuously controls the feed of specialty coagulants used in water treatment to maintain a proper pH level and an optimum particle charge, while simultaneously improving overall treatment process efficiency. For more information, visit www.h2oinnovation.com/services/digital-solutions/.
About H2O Innovation
H2O Innovation designs and provides state-of-the-art, custom-built and integrated water treatment solutions based on membrane filtration technology for municipal, industrial, energy and natural resources end-users. The Corporation’s activities rely on three pillars which are i) water and wastewater projects; ii) specialty products and services, including a complete line of specialty chemicals, consumables, specialized products for the water treatment industry as well as control and monitoring systems; and iii) operation and maintenance services for water and wastewater treatment systems. For more information, visit www.h2oinnovation.com.